Skip to main content

Wang, Weidong

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #2,246
  • Sustained Excellence
  • R01 Holder
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Physiology

NIH Funding · FY2023

Linked Award Amount
$2.7M
Full award amounts, FY2023
Award Records
10
Records listing this PI
Award-Linked Rank
#2,246
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Wang, Weidong. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Wang, Weidong as a PI. Multi-PI records show the full award amount for context.

  • 5R01DK128848-03R01Contact PI
    Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
    $460.1K
    award amount
  • 1ZIAAG000686-04ZIAContact PI
    Investigation of whether Topoisomerase 3b can be a drug target for SARS-CoV-2 and other positive-strand RNA virus; and development of such a drug
    $429.4K
    award amount
  • 5R01DK130174-02R01Contact PI
    Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment
    $384.2K
    award amount
  • 1ZIAAG000502-01ZIAContact PI
    Investigating roles of Topoisomerase 3b (TOP3B) in immune responses to infection by coronavirus and bacteria
    $375.7K
    award amount
  • 1ZIAAG000501-01ZIAContact PI
    Investigating the roles of a Topoisomerase complex in autophagy and lifespan regulation
    $322.1K
    award amount
  • 1ZIAAG000692-04ZIAContact PI
    Investigating the roles of Topoisomerase 3b-TDRD3 complex in neurodegeneration and Alzheimer's disease
    $268.2K
    award amount
  • 1ZIAAG000495-02ZIAContact PI
    Investigating the roles of RNA-binding proteins Nocte and PRRC2 in mRNA translation and age-related neurodegeneration using Drosophila and mouse models
    $214.7K
    award amount
  • 1ZIAAG000486-03ZIAContact PI
    Investigating a novel shelterin-associated protein complex in telomere protection
    $161K
    award amount
  • 1ZIAAG000689-13ZIAContact PI
    An RNA topoisomerase complex interacts with Fragile X syndrome protein to promote neurodevelopment and maintain normal life-span
    $48.3K
    award amount
  • 1ZIAAG000688-22ZIAContact PI
    Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins
    $26.8K
    award amount

Award organizations

Organizations that administered FY2023 awards listing Wang, Weidong as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2007
    First NIH Award
    National Institute On Aging
  2. 2007
    $500K Cumulative Funding
  3. 2007
    $1M Cumulative Funding
  4. 2007
    Entered Top 50% Nationally
    Ranked #4078
  5. 2007
    Entered Top 25% Nationally
    Ranked #4078
  6. 2008
    $2M Cumulative Funding
  7. 2008
    Multi-Institutional Research
    Awards at 2 institutions
  8. 2010
    $5M Cumulative Funding
  9. 2012
    $10M Cumulative Funding
  10. 2012
    R01 Grant Holder
  11. 2016
    Entered Top 10% Nationally
    Ranked #1620
  12. 2018
    $25M Cumulative Funding
  13. 2018
    Entered Top 5% Nationally
    Ranked #693